Form 8-K GENTEX CORP For: Jul 24
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140724/AQKZT222Z222K2E2222P22Z2NOHMZR225H62
Filed on: July 24, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A New Era in Medical Tourism: Patients Are No Longer Choosing Only the Treatment, but the System That Manages It
- Apex Drills 14.9 m of 5.09 % REO and 12.3 m of 5.63 % REO with > 2.50 % REO Intercept Over 191.9 m in the Trinity Zone at the Rift Rare Earth Project
- Oxford BioTherapeutics' Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
